Literature DB >> 18598190

Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin.

Valérie Briand1, Lise Denoeud, Achille Massougbodji, Michel Cot.   

Abstract

BACKGROUND: In West Africa, treatment for the prevention of malaria during pregnancy has recently changed from chloroquine (CQ) prophylaxis to intermittent preventive treatment (IPTp). We assessed the benefits of IPTp with respect to those of CQ, using a before-after study.
METHODS: CQ efficacy was evaluated during a cross-sectional survey conducted in Benin between April 2004 and April 2005. IPTp efficacy was assessed using data from an ongoing clinical trial to compare sulfadoxine-pyrimethamine with mefloquine that began in the same maternity clinics during July 2005; the present analysis is limited to women who delivered between November 2005 and November 2006. Treatment assignments were not unblinded. We compared the efficacy of the 2 strategies against low birth weight and placental infection by performing multiple logistic regressions.
RESULTS: A total of 1699 women (1090 in the CQ group and 609 in the IPTp group) who delivered live singletons were analyzed. Characteristics of women in the CQ group were similar to those of women in the IPTp group. We showed that women in the IPTp group had a significantly decreased risk of delivering an infant with a low birth weight (adjusted odds ratio [aOR], 0.54; 95% confidence interval [CI], 0.38-0.78) and placental infection (aOR, 0.15; 95% CI, 0.09-0.24).
CONCLUSION: We clearly evidenced that IPTp is substantially more beneficial than CQ for the prevention of malaria during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598190     DOI: 10.1086/590114

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.

Authors:  Valérie Briand; Sylvie Escolano; Valérie Journot; Achille Massougbodji; Michel Cot; Pascale Tubert-Bitter
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

2.  Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.

Authors:  Agnès Le Port; Gilles Cottrell; Célia Dechavanne; Valérie Briand; Aziz Bouraima; José Guerra; Isabelle Choudat; Achille Massougbodji; Benjamin Fayomi; Florence Migot-Nabias; André Garcia; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

3.  Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA.

Authors:  Cyril Badaut; Gwladys Bertin; Tatiana Rustico; Nadine Fievet; Achille Massougbodji; Alioune Gaye; Philippe Deloron
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

4.  Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.

Authors:  Innocent Valea; Halidou Tinto; Maminata Traore-Coulibaly; Laeticia C Toe; Niklas Lindegardh; Joel Tarning; Jean-Pierre Van Geertruyden; Umberto D'Alessandro; Geraint R Davies; Stephen A Ward
Journal:  J Antimicrob Chemother       Date:  2014-06-02       Impact factor: 5.790

5.  Rational case management of malaria with a rapid diagnostic test, Paracheck Pf®, in antenatal health care in Bangui, Central African Republic.

Authors:  Alexandre Manirakiza; Eugène Serdouma; Luc Salva Heredeïbona; Djibrine Djalle; Nestor Madji; Methode Moyen; Georges Soula; Alain Le Faou; Jean Delmont
Journal:  BMC Public Health       Date:  2012-06-26       Impact factor: 3.295

6.  Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.

Authors:  Henriette A Vanga-Bosson; Patrick A Coffie; Serge Kanhon; Caroline Sloan; Firmin Kouakou; Serge P Eholie; Moussa Kone; François Dabis; Hervé Menan; Didier K Ekouevi
Journal:  Malar J       Date:  2011-04-29       Impact factor: 2.979

7.  Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells.

Authors:  Nadine Fievet; Stefania Varani; Samad Ibitokou; Valérie Briand; Stéphanie Louis; René Xavier Perrin; Achille Massougbogji; Anne Hosmalin; Marita Troye-Blomberg; Philippe Deloron
Journal:  Malar J       Date:  2009-11-05       Impact factor: 2.979

8.  Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria.

Authors:  Olorunfemi E Amoran; Adebayo A Ariba; Christy A Iyaniwura
Journal:  Reprod Health       Date:  2012-08-13       Impact factor: 3.223

9.  Malaria in pregnancy.

Authors:  Ebako Ndip Takem; Umberto D'Alessandro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

10.  [Intermittent preventive treatment with sulfadoxine--pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso].

Authors:  Sanata Bamba; Adama Séré; Rodrigues Nikiéma; Tinto Halidou; Blandine Thiéba; Blami Dao; Robert Tinga Guiguemdé
Journal:  Pan Afr Med J       Date:  2013-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.